Patents by Inventor Chunlei Li

Chunlei Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160000726
    Abstract: Purified therapeutic nanoparticles are provided herein. Such nanoparticles comprise an active pharmaceutical ingredient and human serum albumin, wherein the weight ratio of human serum albumin to the active ingredient in the therapeutic nanoparticles is from 0.01:1 to 1:1, and wherein the nanoparticles are substantially free of free human serum albumin that is not incorporated in the nanoparticles. The present disclosure also provides pharmaceutical compositions that comprise the purified therapeutic nanoparticles and are also substantially free of free human serum albumin. Methods for preparing and using the purified therapeutic nanoparticles and compositions thereof are also provided.
    Type: Application
    Filed: July 2, 2015
    Publication date: January 7, 2016
    Inventors: Chunlei Li, Yanhui Li, Min Liang, Caixia Wang, Yajuan Wang, Shixia Wang, Dongjian Chen, Yongfeng Li
  • Publication number: 20150143462
    Abstract: Disclosed is an Internet of things capability integration system, which relates to the field of Internet of things, and the field of telecommunication network and Internet.
    Type: Application
    Filed: December 26, 2012
    Publication date: May 21, 2015
    Inventor: Chunlei Li
  • Publication number: 20150030672
    Abstract: A liposome comprising bilayer and inner water phase is disclosed. Said inner water phase may contain sulfobutyl ether cyclodextrin and an active compound.
    Type: Application
    Filed: September 25, 2014
    Publication date: January 29, 2015
    Inventors: Chunlei LI, Lan ZHANG, Caixia WANG, Li ZHANG, Dongmin SHEN, Yanhui LI, Xian XIU, Min LIANG, Yongfeng LI
  • Patent number: 8871253
    Abstract: A liposome comprising bilayer and inner water phase is disclosed. Said inner water phase contains sulfobutyl ether cyclodextrin and active compound. Said sulfobutyl ether cyclodextrin is sulfobutyl ether ?-cyclodextrin, sulfobutyl ether ?-cyclodextrin, or sulfobutyl ether ?-cyclodextrin.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: October 28, 2014
    Assignee: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
    Inventors: Chunlei Li, Lan Zhang, Caixia Wang, Li Zhang, Dongmin Shen, Yanhui Li, Xian Xiu, Min Liang, Yongfeng Li
  • Publication number: 20120201874
    Abstract: A liposome comprising bilayer and inner water phase is disclosed. Said inner water phase contains sulfobutyl ether cyclodextrin and active compound. Said sulfobutyl ether cyclodextrin is sulfobutyl ether ?-cyclodextrin, sulfobutyl ether ?-cyclodextrin, or sulfobutyl ether ?-cyclodextrin.
    Type: Application
    Filed: October 26, 2010
    Publication date: August 9, 2012
    Applicant: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHINJIAZHUANG) CO., LTD.
    Inventors: Chunlei Li, Lan Zhang, Caixia Wang, Li Zhang, Dongmin Shen, Yanhui Li, Xian Xiu, Min Liang, Yongfeng Li
  • Publication number: 20110002977
    Abstract: The present invention relates to a liposomal pharmaceutical preparation containing a multivalent ionic drug, a process for the preparation of the liposomal pharmaceutical preparation, and a use thereof in the treatment of diseases, in which the liposome has a size of about 30-80 nm, and the phospholipid bilayer has a phospholipid with a Tm higher than body temperature, so that the phase transition temperature of the liposome is higher than the body temperature.
    Type: Application
    Filed: December 29, 2007
    Publication date: January 6, 2011
    Inventors: Chunlei Li, Jinxu Wang, Caixia Wang, Yanhui Li, Dongmin Shen, Wenmin Guo, Li Zhang, Lan Zhang